华夏国证疫苗与生物科技指数发起A(016355)资产负债表
| |
2025-12-31 |
2025-06-30 |
2024-12-31 |
2024-06-30 |
| 资产 |
| 银行存款 |
- |
- |
- |
- |
| 结算备付金 |
66,297.73 |
16,282.75 |
25,399.69 |
35,801.82 |
| 存出保证金 |
64,791.95 |
8,426.96 |
9,624.16 |
10,683.51 |
| 交易性金融资产 |
116,483,198.58 |
69,540,635.58 |
64,746,516.38 |
65,548,004.41 |
| 其中：股票投资 |
116,483,198.58 |
69,540,635.58 |
64,746,516.38 |
65,548,004.41 |
| 债券投资 |
- |
- |
- |
- |
| 资产支持证券投资 |
- |
- |
- |
- |
| 衍生金融资产 |
- |
- |
- |
- |
| 买入返售金融资产 |
- |
- |
- |
- |
| 应收证券清算款 |
334,275.19 |
- |
144,317.53 |
3,801.55 |
| 应收利息 |
- |
- |
- |
- |
| 应收股利 |
- |
- |
- |
- |
| 应收申购款 |
1,317,419.09 |
157,752.17 |
169,356.66 |
570,491.68 |
| 其他资产 |
- |
- |
- |
- |
| 资产总计 |
126,697,872.12 |
74,273,703.58 |
69,185,627.87 |
70,666,699.27 |
| 负 债 |
| 短期借款 |
- |
- |
- |
- |
| 交易性金融负债 |
- |
- |
- |
- |
| 衍生金融负债 |
- |
- |
- |
- |
| 卖出回购金融资产款 |
- |
- |
- |
- |
| 应付证券清算款 |
- |
125,703.48 |
- |
- |
| 应付赎回款 |
3,347,168.40 |
502,246.48 |
502,136.26 |
1,116,449.58 |
| 应付管理人报酬 |
54,472.63 |
29,915.04 |
30,374.48 |
29,682.12 |
| 应付托管费 |
10,894.52 |
5,983.01 |
6,074.89 |
5,936.43 |
| 应付销售服务费 |
23,616.46 |
10,815.98 |
10,992.36 |
10,985.09 |
| 应付交易费用 |
- |
- |
- |
- |
| 应交税费 |
- |
- |
- |
- |
| 应付利息 |
- |
- |
- |
- |
| 应付利润 |
- |
- |
- |
- |
| 其他负债 |
142,265.45 |
60,756.35 |
156,287.91 |
98,200.38 |
| 负债合计 |
3,578,417.46 |
735,420.34 |
705,865.90 |
1,261,253.60 |
| 所有者权益 |
| 实收基金 |
189,957,629.10 |
114,773,808.58 |
104,580,150.91 |
112,628,148.50 |
| 未分配利润 |
-66,838,174.44 |
-41,235,525.34 |
-36,100,388.94 |
-43,222,702.83 |
| 所有者权益合计 |
123,119,454.66 |
73,538,283.24 |
68,479,761.97 |
69,405,445.67 |
| 负债及所有者权益总计 |
126,697,872.12 |
74,273,703.58 |
69,185,627.87 |
70,666,699.27 |
微信公众号
证券之星APP
基本资料
